Evaluation of Next-Generation Anti-CD20 Antibodies Labeled with (89)Zr in Human Lymphoma Xenografts

Radioimmunotherapies with monoclonal antibodies to the B-lymphocyte antigen 20 (CD20) are effective treatments for B-cell lymphomas, but U.S. Food and Drug Administration–approved radioimmunotherapies exclusively use radiolabeled murine antibodies, potentially limiting redosing. The Food and Drug Ad...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Nucl Med
Asıl Yazarlar: Yoon, Jason T., Longtine, Mark S., Marquez-Nostra, Bernadette V., Wahl, Richard L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Society of Nuclear Medicine 2018
Konular:
Oncology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6071500/
https://ncbi.nlm.nih.gov/pubmed/29348316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.117.203299
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller